Advertisement

Hyponatremia

  • Lenar YessayanEmail author
  • Ryan E. Krahn
Chapter
  • 10 Downloads

Abstract

Abnormalities of the plasma sodium concentration are the most common electrolyte disorders encountered in clinical medicine. Appropriate therapy for hyponatremia should keep the patient safe from deleterious complications of hyponatremia while avoiding correction rates that risk brain injury. Skilled management of hyponatremia requires an understanding of the physiologic processes which regulate plasma sodium, the pathologic settings in which it occurs, and the ability to account for factors that affect plasma sodium concentration.

Keywords

Hyponatremia Osmotic demyelination syndrome Brain edema Brain herniation 

References

  1. 1.
    Overgaard-Steensen C. Initial approach to the hyponatremic patient. Acta Anaesthesiol Scand. 2011;55(2):139–48.PubMedCrossRefGoogle Scholar
  2. 2.
    Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106(4):399–403.PubMedCrossRefGoogle Scholar
  3. 3.
    Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1–42.PubMedCrossRefGoogle Scholar
  4. 4.
    Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1–47.PubMedCrossRefGoogle Scholar
  5. 5.
    Yessayan L, Yee J, Frinak S, Szamosfalvi B. Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid. Am J Kidney Dis. 2014;64(2):305–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Yessayan L, Yee J, Frinak S, Szamosfalvi B. Continuous renal replacement therapy for the management of acid-base and electrolyte imbalances in acute kidney injury. Adv Chronic Kidney Dis. 2016;23(3):203–10.PubMedCrossRefGoogle Scholar
  7. 7.
    Verbalis JG. Brain volume regulation in response to changes in osmolality. Neuroscience. 2010;168(4):862–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Brunner JE, Redmond JM, Haggar AM, Kruger DF, Elias SB. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol. 1990;27(1):61–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Edelman IS, Leibman J, O’Meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest. 1958;37(9):1236–56.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Overgaard-Steensen C, Larsson A, Bluhme H, Tonnesen E, Frokiaer J, Ring T. Edelman’s equation is valid in acute hyponatremia in a porcine model: plasma sodium concentration is determined by external balances of water and cations. Am J Physiol Regul Integr Comp Physiol. 2010;298(1):R120–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009;29(3):282–99.PubMedCrossRefGoogle Scholar
  12. 12.
    Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med. 1986;81(6):1033–40.PubMedCrossRefGoogle Scholar
  13. 13.
    Sood L, Sterns RH, Hix JK, Silver SM, Chen L. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis. 2013;61(4):571–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Liamis G, Kalogirou M, Saugos V, Elisaf M. Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant. 2006;21(6):1564–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Lindner G, Schwarz C, Kneidinger N, Kramer L, Oberbauer R, Druml W. Can we really predict the change in serum sodium levels? An analysis of currently proposed formulae in hypernatraemic patients. Nephrol Dial Transplant. 2008;23(11):3501–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Clayton JA, Le Jeune IR, Hall IP. Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. QJM. 2006;99(8):505–11.PubMedCrossRefGoogle Scholar
  17. 17.
    Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83(5):905–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17(7):1820–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Thaler SM, Teitelbaum I, Berl T. “Beer potomania” in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis. 1998;31(6):1028–31.PubMedCrossRefGoogle Scholar
  20. 20.
    Cowen LE, Hodak SP, Verbalis JG. Age-associated abnormalities of water homeostasis. Endocrinol Metab Clin N Am. 2013;42(2):349–70.CrossRefGoogle Scholar
  21. 21.
    Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102(2):164–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064–72.PubMedCrossRefGoogle Scholar
  23. 23.
    Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711–37.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Liamis G, Milionis HJ, Elisaf M. Endocrine disorders: causes of hyponatremia not to neglect. Ann Med. 2011;43(3):179–87.PubMedCrossRefGoogle Scholar
  25. 25.
    Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314(24):1535–42.PubMedCrossRefGoogle Scholar
  26. 26.
    Vu T, Wong R, Hamblin PS, Zajac J, Grossmann M. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes. Hosp Pract (1995). 2009;37(1):128–36.CrossRefGoogle Scholar
  27. 27.
    Avila M. The clinical practice guideline on diagnosis and treatment of hyponatraemia: a response from Otsuka Pharmaceutical Europe Ltd. Eur J Endocrinol. 2014;171(1):L1–3.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Bissram M, Scott FD, Liu L, Rosner MH. Risk factors for symptomatic hyponatraemia: the role of pre-existing asymptomatic hyponatraemia. Intern Med J. 2007;37(3):149–55.PubMedCrossRefGoogle Scholar
  29. 29.
    Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122(9):857–65.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170(3):294–302.PubMedCrossRefGoogle Scholar
  31. 31.
    Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36(2):304–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA. 2007;297(12):1319–31.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Nephrology, Department of Internal MedicineUniversity of Michigan, 3914 Taubman CenterAnn ArborUSA

Personalised recommendations